World Vaccine Congress

Our SMEs are prepared to discuss a wide range of questions that may be top of mind for your company, including:

-How must evidence generation and messages evolve to resonate with ACIP and more sophisticated, integrated customers?

-How might regulatory and policy pathways evolve to support preventive innovations?

-How can providers and patients be best engaged to support vaccine uptake and overcome hesitancy?

-How can provider challenges be addressed to expand the number of immunizers and settings of administration?

-How does variability in Medicare and Medicaid coverage and cost sharing impact access and uptake?

-How can the federal, state, and global vaccine policy landscapes be shaped to drive optimal vaccine access and uptake?

-How can policy, provider, and patient advocacy stakeholders be activated to support access to immunizations?